Prosthetic Joint Infections of Hip
7
0
3
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
14.3%
1 terminated out of 7 trials
0.0%
-86.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection
Antibiotic-coated Braided Suture Study
Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection
Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial
Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection